Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Exchange Rate Effect (2016 - 2025)

Kiora Pharmaceuticals (KPRX) has disclosed Exchange Rate Effect for 11 consecutive years, with $13154.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Exchange Rate Effect fell 78.89% year-over-year to $13154.0, compared with a TTM value of $79394.0 through Sep 2025, down 43.47%, and an annual FY2024 reading of -$57231.0, down 258.89% over the prior year.
  • Exchange Rate Effect was $13154.0 for Q3 2025 at Kiora Pharmaceuticals, down from $131582.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $131582.0 in Q2 2025 and bottomed at -$75485.0 in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $5677.5, with a median of -$9489.5 recorded in 2021.
  • Peak annual rise in Exchange Rate Effect hit 4943.93% in 2021, while the deepest fall reached 21713.45% in 2021.
  • Year by year, Exchange Rate Effect stood at -$27132.0 in 2021, then soared by 242.54% to $38675.0 in 2022, then soared by 215.93% to $122184.0 in 2023, then plummeted by 161.78% to -$75485.0 in 2024, then surged by 117.43% to $13154.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for KPRX at $13154.0 in Q3 2025, $131582.0 in Q2 2025, and $10143.0 in Q1 2025.